Dr. Rajesh Ponugupati. EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. J Popl Ther Clin Pharmacol 2016, 23 (2), 237-246. https://doi.org/10.53555/am143177.